Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds

Peptidomimetic inhibitors mimic natural peptide substrates, employing electrophilic warheads to covalently interact with the catalytic Cys145 of Mpro. Examples include aldehydes, α-ketoamides, and aza-peptides, with discussions on their mechanisms of action, potency, and structural insights. Non-pep...

Full description

Saved in:
Bibliographic Details
Main Authors: Noor Atatreh, Radwa E. Mahgoub, Mohammad A. Ghattas
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2025.2460045
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832086569870163968
author Noor Atatreh
Radwa E. Mahgoub
Mohammad A. Ghattas
author_facet Noor Atatreh
Radwa E. Mahgoub
Mohammad A. Ghattas
author_sort Noor Atatreh
collection DOAJ
description Peptidomimetic inhibitors mimic natural peptide substrates, employing electrophilic warheads to covalently interact with the catalytic Cys145 of Mpro. Examples include aldehydes, α-ketoamides, and aza-peptides, with discussions on their mechanisms of action, potency, and structural insights. Non-peptidomimetic inhibitors utilise diverse scaffolds and mechanisms, achieving covalent modification of Mpro.
format Article
id doaj-art-4abb7f23fa88442295296b2bae63f9f5
institution Kabale University
issn 1475-6366
1475-6374
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj-art-4abb7f23fa88442295296b2bae63f9f52025-02-06T11:35:14ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742025-12-0140110.1080/14756366.2025.2460045Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffoldsNoor Atatreh0Radwa E. Mahgoub1Mohammad A. Ghattas2College of Pharmacy, Al Ain University, Abu Dhabi, United Arab EmiratesCollege of Pharmacy, Al Ain University, Abu Dhabi, United Arab EmiratesCollege of Pharmacy, Al Ain University, Abu Dhabi, United Arab EmiratesPeptidomimetic inhibitors mimic natural peptide substrates, employing electrophilic warheads to covalently interact with the catalytic Cys145 of Mpro. Examples include aldehydes, α-ketoamides, and aza-peptides, with discussions on their mechanisms of action, potency, and structural insights. Non-peptidomimetic inhibitors utilise diverse scaffolds and mechanisms, achieving covalent modification of Mpro.https://www.tandfonline.com/doi/10.1080/14756366.2025.2460045Anti-viralirreversible inhibitioncovalent inhibitorCovid-19warheads reactivity
spellingShingle Noor Atatreh
Radwa E. Mahgoub
Mohammad A. Ghattas
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
Journal of Enzyme Inhibition and Medicinal Chemistry
Anti-viral
irreversible inhibition
covalent inhibitor
Covid-19
warheads reactivity
title Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
title_full Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
title_fullStr Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
title_full_unstemmed Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
title_short Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
title_sort exploring covalent inhibitors of sars cov 2 main protease from peptidomimetics to novel scaffolds
topic Anti-viral
irreversible inhibition
covalent inhibitor
Covid-19
warheads reactivity
url https://www.tandfonline.com/doi/10.1080/14756366.2025.2460045
work_keys_str_mv AT nooratatreh exploringcovalentinhibitorsofsarscov2mainproteasefrompeptidomimeticstonovelscaffolds
AT radwaemahgoub exploringcovalentinhibitorsofsarscov2mainproteasefrompeptidomimeticstonovelscaffolds
AT mohammadaghattas exploringcovalentinhibitorsofsarscov2mainproteasefrompeptidomimeticstonovelscaffolds